Project Grant R61DA062357
Award Date
9/30/24
Completion Date
8/31/26
Dollars Obligated
$2.4M
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to evaluate the protective role of American Indian ceremonial practices against substance use for adult participants. The $1,154,212 award to The Johns Hopkins University will fund a randomized controlled trial (n=300) to assess the impact of ceremonial engagement (Gii'igoshimong) on substance use behaviors, related outcomes, and overall health among...
This $176,326 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports a study to reduce opioid misuse among urban Indigenous young adults in Montana. The principal investigator, Dr. Damian Chase-Begay, will rigorously adapt an evidence-based substance abuse prevention intervention to incorporate traditional ceremonial practices and then test the effectiveness of the adapted intervention at five urban...
The National Institute on Drug Abuse (NIDA) awarded a $809,922 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Colorado-Denver. The grant, titled "Preparing Indigenous Scientists to Lead Innovative Substance Use Research: The Native Children's Research Exchange Scholars Program," aims to foster the development of early career Indigenous substance use and disorder researchers, particularly those focusing on the impacts and...
This federal Project Grant award of $1,965,600.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to leverage genome-wide and epigenome-wide association studies to reveal altered mechanisms in nicotine metabolism among American Indian (AI) smokers. The research will evaluate associations between genomic and epigenomic variation with nicotine metabolism, predict risk factors for smoking behavior and health outcomes, and...
The National Institute on Drug Abuse (NIDA) awarded a $1,076,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Dynamicare Health Inc. in Wareham, MA. The award will fund a Phase II randomized clinical trial to evaluate the efficacy of DCH-003, a digital therapeutic that delivers contingency management for the treatment of stimulant use disorder. The trial will compare standard clinic care plus DCH-003 to standard care plus a sham digital app, with the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to conduct a randomized clinical trial to evaluate the effectiveness of targeted cognitive skills training for offenders with substance use disorders. The $3,226,170 award to the Lovelace Biomedical Research Institute will assess whether matching specific cognitive-emotional deficits in offenders to tailored interventions can improve outcomes,...
This Project Grant award of $1,874,079.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to develop and evaluate a culturally-tailored substance use prevention intervention for urban Indigenous youth in the Southwest. The key objectives are to: 1) Identify multilevel risk and protective factors for nicotine and cannabis vaping among urban Indigenous youth; 2) Test the efficacy of an adapted "Living in...
This Project Grant award of $220,340 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research at Washington State University to investigate the role of microglia, a type of immune cell in the brain, as a mechanism underlying the cognitive deficits associated with adolescent cannabis use. The study aims to determine if microglial activation is necessary for the impairments in cognitive flexibility observed in adulthood...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,178,880 to the University of Washington to conduct research on the "MODELING WEEKLY AND DAILY PROCESSES OF A HIGH-RISK FEEDBACK CYCLE OF ALCOHOL, CANNABIS, AND NONMEDICAL USE OF PRESCRIPTION STIMULANTS IN COLLEGE STUDENTS: IMPACTS ON USE, ACADEMICS, AND SLEEP." The project aims to examine the mechanisms underlying the...
This $195,728 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a study to assess the acceptability and feasibility of using pharmacogenomic (PGx) testing to guide opioid use disorder (OUD) treatment. The key objectives are to: Identify barriers and facilitators to implementing a PGx testing protocol for OUD treatment by engaging patients, providers, and administrators. Develop and evaluate...